14 results
P
patients with rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA)
I/C
coeliac disease (CD), biopsy-confirmed CD in RA and JIA patients
O
pooled prevalence estimates of biopsy-confirmed CD and positive CD serology
P
patients with rare disease, caregivers
I/C
health-related quality of life (HRQOL), other chronic disease groups, general population in Hong Kong
O
lower HRQOL
P
Liu S, Silikas N, Ei-Angbawi A
I/C
fiber-reinforced composite lingual retainer
O
effectiveness
P
South Africa, India, Turkey, Pakistan, Canada, Hong Kong, China
I/C
α-HCH, β-HCH, γ-HCH, ∑-HCH, Heptachlor, Aldrin, p,p'-DDE, p,p'-DDT, ∑-DDT, ∑-OCP, Surface water, Drinking water, Seawater, Groundwater
O
Concentration and prevalence of POPs, Carcinogenic risk, Non-carcinogenic risk
P
Chinese children under 18 years old
I/C
urban vs. rural areas, Northern China vs. Southern China, Hong Kong, Macau and Taiwan vs. mainland China
O
prevalence of refractive error (myopia, high myopia, hyperopia, astigmatism)
P
female patients with primary dysmenorrhea
I/C
sham acupuncture, no intervention or other treatments
O
pain intensity, retrospective symptom scale, health-related quality of life
P
5293
I/C
total glucosides of paeony, placebo, standard treatment
O
disease activity score (ASDAS), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tumor necrosis factor (TNF)-α, interleukin (IL)-6, 28 joints disease activity (DAS28), psoriasis area and severity index (PASI), visual analogue scale (VAS), nitric oxide (NO)
P
youth
I/C
treatments, existing treatments
O
behavior problems, callous-unemotional traits
P
patients with autoimmune disease and associated inflammatory ocular diseases
I/C
Janus kinase (JAK) inhibitors, . None of these 11 patients responded adequately to conventional treatments, including biological agents; these were all refractory cases and switched to JAK inhibitor therapy.
O
all 11 patients showed an improvement to JAK inhibitors without significant side effects